LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

BACKGROUND: Adriamycin (ADR) resistance is one of the main obstacles to improving the clinical prognosis of breast cancer patients. Long noncoding RNAs (lncRNAs) can regulate cell behavior, but the role of these RNAs in the anti-ADR activity of breast cancer remains unclear. Here, we aim to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming, Wang, Yan, Jiang, Longyang, Song, Xinyue, Zheng, Ang, Gao, Hua, Wei, Minjie, Zhao, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830819/
https://www.ncbi.nlm.nih.gov/pubmed/33494806
http://dx.doi.org/10.1186/s13046-021-01844-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830819/
https://www.ncbi.nlm.nih.gov/pubmed/33494806
http://dx.doi.org/10.1186/s13046-021-01844-7

Ejemplares similares